Alife Health Receives CE Mark Under European Medical Device Regulation for Embryo Predict™, Its AI-Powered Embryo Selection Tool
Alife Health, a health tech company advancing the future of fertility care with artificial intelligence, today announced that Embryo Predict™, its AI-powered embryo selection tool, has received CE Mark certification under the European Medical Device Regulation (MDR). This approval marks a new era for Alife's expansion into international markets and brings its cutting-edge technology to […]